AzTrials
AzTrials

Pelvic Floor DisordersNCT06867341

Monocentric Prospectiv Observational Clinical Trial of Pelvic Floor Biometry During Pregnancy and Puerperium

An observational study of Pelvic Floor Disorders and Pelvic Floor Distress and Impact Scores, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Pregnancy, childbirth and the puerperium determine significant changes in the muscular, fascial and support structures of the pelvic floor. These changes, both physiological (i.e. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
How many people
350 participants
Where
1 siteItaly
Study dates
17 Jan 2023to 31 Dec 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients will be consecutively enrolled in the three trimesters of pregnancy and in the puerperium, nulliparous, and who did not report pelvic static disorders at the time of enrollment (fecal and urinary incontinence and symptoms of genital prolapse).

Who may be able to join

  • single pregnancy confirmed by ultrasound in the first trimester (within 10 weeks of gestational age),
  • maternal age between 18 and 40 years,
  • patients who speak Italian correctly and/or who can perfectly understand what was expressed at the time of enrollment.
  • spontaneous vaginal births, operative and current cesarean section
  • patients who do not report urinary and fecal incontinence or pelvic organ prolapse at enrollment.

Who cannot join

  • previous pregnancy ended with spontaneous vaginal delivery or cesarean section
  • pelvic floor reconstructive surgery
  • gynecological cancer
  • pelvic radiation therapy for previous oncological disease
  • previous pelvic trauma
  • known connective tissue disease
  • body mass index >40 kg / m2.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Arsenio Spinillo contact

+39382503267

spinillo@smatteo.pv.it

Italy1 site, 1 recruiting
  • Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia 1

    Pavia, Pavia, 27100

    Arsenio Spinillo, MD, +390382503267, spinillo@smatteo.pv.it

    Recruiting

Other trials in Italy

About this study

Official title: Monocentric Prospectiv Observational Clinical Trial of Pelvic Floor Biometry During Pregnancy and Puerperium : Relationship with Symptoms Related to Post-partum Pelvic Floor Dysfunction

Pregnancy, childbirth and the puerperium determine significant changes in the muscular, fascial and support structures of the pelvic floor. These changes, both physiological (i.e. dictated by the adaptations that pregnancy determines at the level of the connective tissue, collagen and pelvic-perineal muscular structures) and the changes induced by the passage of the fetus through the birth canal (obstetric lacerations, episiotomy and muscle avulsions) cause a weakening of the pelvic support structures with the possible onset of dysfunctional symptoms, which are not only common in old age, but become evident already in childbearing age. Previous studies on the composition of connective tissue show significant changes in the collagen component both in continent women and in those who experience stress urinary incontinence. These changes are revealed in approximately 24% of the population that suffers from urinary incontinence. Collagen is the main component of the endopelvic fascia. During pregnancy, the hormonal influence typical of this phase determines significant changes in the mechanical properties of the connective tissue and muscle fibers of the levator ani, which tend to hypertrophy and lengthen. This may also explain why cesarean delivery, elective or after the onset of labor, is not fully protective against the development of pelvic floor dysfunction. However, pelvic floor changes may have occurred before delivery and may not necessarily be related to labor and delivery itself. Incontinence, mostly temporary in pregnancy, must be interpreted as the result of these factors in addition to the increased pressure on the urethrovesical junction caused by the gravid uterus. Stretching of connective tissues beyond their physiological limits during labor, resulting in levator ani injury and/or possible neurogenic stretch damage, occurs in the majority of women who give birth vaginally, but in most women, muscle hypertrophy and nerve fiber adaptation compensate for this pathological pattern. In a minority (5-20%) of women, major levator ani defects and neurogenic lesion may lead to irreversible changes in pelvic floor function. Pelvic floor imaging after pregnancy has improved the understanding of the etiology of pelvic floor disorders in animal models. Patients who already present with pelvic static dysfunction and urinary incontinence during pregnancy tend to develop the same problems in the puerperium. However, to date it is not known what moment in pregnancy these changes in the pelvic tissue begin and that cause the progressive change in the myo-connective components of pregnancy. The lack of prospective cohort studies of pregnant and postpartum subjects does not allow a conclusive opinion on this topic. Pelvic floor ultrasound performed transpeineally, useful for evaluating pelvic biometry, is a non-invasive method and well tolerated by the patient, not only in postpartum but also during pregnancy. A previous study examined pelvic floor changes during pregnancy, reporting how the progression of pregnancy determines changes in the anatomical components of the pelvic floor, without however correlating the data with the puerperium and the longer-term outcomes of these changes. We did not identify any previously published studies that attempted to comprehensively assess biometric changes of the pelvic floor during pregnancy and postpartum using not only ultrasound imaging, but also clinical assessment and validated urinary symptom questionnaires.

Medical subject headings
Pelvic Floor Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06867341
Study groupRoleWhat they receive
PREGNAANT WOMENNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pelvic floor biometry

    evaluate the association between the biometry of the pelvic floor and the presence of symptoms such as urinary and fecal incontience, pelvic weight and vaginal congestion typical of genital prolapse, related to pelvic-perineal dysfunction at the check-up carried out 6 months after delivery. Specifically, the following end-points will be evaluated: pelvic hiatus area, measured in the last trimester of pregnancy and in the post-partum

    Measured: baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery

Secondary outcomes (1)
  1. pelvic floor biometry

    1. time course of the pelvic hiatus area
    2. time course of the anteroposterior diameter
    3. time course of the transverse diameter of the pelvic hiatus
    4. time course of the presence/intensity of symptoms based on the score obtained in the PDFI questionnaire

    Measured: baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2025
  2. Study start17 Jan 2023
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
350 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06867341
Sponsor's protocol ID
PavPel
Status last verified
Feb 2025
First submitted
4 Mar 2025
Last updated
10 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Solans-Domenech M, Sanchez E, Espuna-Pons M; Pelvic Floor Research Group (Grup de Recerca del Sol Pelvia; GRESP). Urinary and anal incontinence during pregnancy and postpartum: incidence, severity, and risk factors. Obstet Gynecol. 2010 Mar;115(3):618-628. doi: 10.1097/AOG.0b013e3181d04dff.

    PubMed 20177295
  • Costantini S, Esposito F, Nadalini C, Lijoi D, Morano S, Lantieri P, Mistrangelo E. Ultrasound imaging of the female perineum: the effect of vaginal delivery on pelvic floor dynamics. Ultrasound Obstet Gynecol. 2006 Feb;27(2):183-7. doi: 10.1002/uog.2663.

    PubMed 16388512

Questions about this trial

What is this clinical trial studying?

An observational study of Pelvic Floor Disorders and Pelvic Floor Distress and Impact Scores, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Arsenio Spinillo (+39382503267, spinillo@smatteo.pv.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pelvic floor biometry (time frame: baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06867341, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in